Translate
Sutro Biopharma, Inc.
About
29.58USD-0.12 -0.39%
Closed • Updated at 14:50 GMT+00:00Market Cap$490.07M
Volume34.0K
Beta1.58
RSI42.40
Gross Margin93.27%
Sutro Biopharma, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 14 2026
Sutro Biopharma Reports First Quarter 2026 Financial Results and Business Highlights
Apr 19 2026
Sutro Biopharma Presents Promising Preclinical Data Across its Pipeline of Next-Generation Single and Dual-Payload ADC Programs at AACR 2026
Mar 23 2026
Sutro Biopharma Reports Full Year 2025 Financial Results and Business Highlights
Feb 23 2026
Sutro Biopharma Announces Participation at the 16th World ADC London Summit
Feb 10 2026
Sutro Biopharma Announces Pricing of $110.0 million Underwritten Offering
Recent Videos
Sutro Biopharma's Rollercoaster: Layoffs, Leadership Changes, and Luvelta's Future
May 07, 2026
STRO daily signal | Sutro Biopharma #Shorts
Apr 23, 2026
20 abril 26. Noticias acciones biotecnológicas. Resumen diario. #Español #Shorts #diario $XBI #bio
Apr 20, 2026
Inside Biotech Leadership: Bill Newell on Innovation, Capital, and Policy at Sutro Biopharma
Nov 13, 2025
Community Chat
Ask AI
Try asking